Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.

Malaria journal - 12 Apr 2010

Li Changling, Wang Rui, Wu Yuan, Zhang Dongmei, He Zhicheng, Pan Weiqing

Abstract excerpt

BACKGROUND: Apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP1) of Plasmodium falciparum are two leading blood-stage malaria vaccine candidates. A P. falciparum chimeric protein 2.9 (PfCP-2.9) has been constructed as a vaccine candidate, by fusing AMA-1 domain III (AMA-1 (III...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epitope Mapping
Share to Epitopes
Share to Erythrocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Malaria, Falciparum

Share to Malaria Vaccines

Share to Pichia

Share to Plasmodium falciparum

Share to Vaccines, Synthetic

Source

Open in PubMed Open full text

Identifiers

PMID: 20384992
DOI: 10.1186/1475-2875-9-94
PMCID: PMC2883548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20384992-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.PMID 20384992Read ↗

Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals.Semantic proximity Read ↗

Multi-protein chimeric antigens, a novel combined approach for efficiently targeting and blocking the blood stage of <i>Plasmodium falciparum</i>Semantic proximity Read ↗

An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodiesSemantic proximity Read ↗

New antigens for a multicomponent blood-stage malaria vaccineSemantic proximity Read ↗

Systematic Serological Diversity of a Putative Malaria Vaccine Candidate and Broad ProtectionSemantic proximity Read ↗

Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparumSemantic proximity Read ↗

Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4Semantic proximity Read ↗

Structural characterization of MAM01 and other cost-effective engineered monoclonal antibodies for malaria preventionSemantic proximity Read ↗

A Conserved Multi-Gene Family Induces Cross-Reactive Antibodies Effective in Defense against Plasmodium falciparumSemantic proximity Read ↗

Targeting a malaria merozoite surface protein with mRNA vaccine generates multifunctional antibodiesSemantic proximity Read ↗

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119Semantic proximity Read ↗

Identification of a Conserved Region of<i>Plasmodium falciparum</i>MSP3 Targeted by Biologically Active Antibodies to Improve Vaccine DesignSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.